By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Appoints Michael Becker As Senior Vice President Of Finance And Corporate Development 11/4/2014 9:05:50 AM
Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants 10/16/2014 6:40:51 AM
Relmada Therapeutics Appoints Julie J. Chen As Director Of Finance and Operations 10/2/2014 9:15:13 AM
Relmada Therapeutics Appoints Christopher W. James As Senior Director Of Clinical Development 9/18/2014 9:00:07 AM
Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER 9/16/2014 8:58:29 AM
Relmada Therapeutics Announces The Filing Of Clinical Trial Application In Canada For d-methadone 9/10/2014 7:49:10 AM
Relmada Therapeutics Provides Its First Corporate Update As A Public Company 9/9/2014 8:56:07 AM
Relmada Therapeutics To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2014 9/4/2014 2:14:50 PM
Relmada Therapeutics Completes Name Change And Announces New Ticker 8/6/2014 9:03:55 AM
Camp Nine Inc. Announces Corporate Name Change To Relmada Therapeutics 7/9/2014 9:30:01 AM